IMAC Holdings Inc (BACK) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4

Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc...

Form S-4/A - Registration of securities, business combinations: [Amend]

Form S-4/A - Registration of securities, business combinations: [Amend]

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board

Golden, Colorado, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a...

Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023

Golden, Colorado, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or...

Form S-4 - Registration of securities, business combinations

Form 8-K - Current report

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

Franklin, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”...

Form 8-K - Current report

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Franklin, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]